|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
doi: 10.1242/10.1242/dev.00477
DEVELOPMENT AND DISEASE |
National Human Genome Research Institute, NIH, 49 Convent Drive, Bethesda, MD 20892, USA
* Author for correspondence (e-mail: jsegre{at}nhgri.nih.gov)
Accepted 11 March 2003
Dysfunction of the epidermal permeability barrier can result in dehydration, electrolyte imbalance and poor thermoregulation. Immature skin is a portal of entry for infectious agents and potential toxins in topically applied substances. As the skin is one of the last organs to mature in utero, premature infants born before 34 weeks gestation are at great risk for complications. The transcription factor kruppel-like factor 4 (Klf4), has been shown by a targeted ablation, to have an essential function in barrier acquisition. We investigated whether Klf4 expression in utero is sufficient to establish the epidermal barrier. Specifically, we generated lines of mice that express Klf4 from a tetracycline inducible promoter when crossed with transgenic mice expressing the tetracycline transactivator tTA from the epidermal keratin 5 promoter. These mice exhibit acceleration in barrier acquisition as manifest by the exclusion of a dye solution one day earlier in development than controls. Underlying this dye impermeability are morphological changes, including an increased number of stratified layers, expression of terminal differentiation markers and assembly of cornified envelopes. By all criteria, Klf4 ectopic expression accelerates the normal process of terminal differentiation. Premature barrier acquisition in these mice follows the normal pattern rather than the pattern of the transgene promoter, indicating that there are fields of competence in which KLF4 acts. Although other transgenic mice have perturbed barrier acquisition, these mice are the first to accelerate the process of barrier establishment. These studies show that KLF4 regulates barrier acquisition and provides an animal model for studying how to accelerate the process of barrier acquisition for the premature infant.
Key words: KLF4, Epidermis, Permeability barrier, Perinatal mortality, Mouse
This article has been cited by other articles:
|
|
 |
|
  S. D. Cho, S. Chintharlapalli, M. Abdelrahim, S. Papineni, S. Liu, J. Guo, P. Lei, A. Abudayyeh, and S. Safe 5,5'-Dibromo-bis(3'-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cells Mol. Cancer Ther., July 1, 2008; 7(7): 2109 - 2120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Kharas, I. Yusuf, V. M. Scarfone, V. W. Yang, J. A. Segre, C. S. Huettner, and D. A. Fruman KLF4 suppresses transformation of pre-B cells by ABL oncogenes Blood, January 15, 2007; 109(2): 747 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Radoja, A. Gazel, T. Banno, S. Yano, and M. Blumenberg Transcriptional profiling of epidermal differentiation Physiol Genomics, January 12, 2007; 27(1): 65 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Swamynathan, J. P. Katz, K. H. Kaestner, R. Ashery-Padan, M. A. Crawford, and J. Piatigorsky Conditional Deletion of the Mouse Klf4 Gene Results in Corneal Epithelial Fragility, Stromal Edema, and Loss of Conjunctival Goblet Cells Mol. Cell. Biol., January 1, 2007; 27(1): 182 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Hu, Z. Wu, T. Liu, M. R. Ullenbruch, H. Jin, and S. H. Phan Gut-Enriched Kruppel-Like Factor Interaction with Smad3 Inhibits Myofibroblast Differentiation Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 78 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Patel, Z. F. Xi, E. Y. Seo, D. McGaughey, and J. A. Segre Klf4 and corticosteroids activate an overlapping set of transcriptional targets to accelerate in utero epidermal barrier acquisition PNAS, December 5, 2006; 103(49): 18668 - 18673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. de Guzman Strong, P. W. Wertz, C. Wang, F. Yang, P. S. Meltzer, T. Andl, S. E. Millar, I-C. Ho, S.-Y. Pai, and J. A. Segre Lipid defect underlies selective skin barrier impairment of an epidermal-specific deletion of Gata-3 J. Cell Biol., November 20, 2006; 175(4): 661 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Sur, B. Rozell, V. Jaks, A. Bergstrom, and R. Toftgard Epidermal and craniofacial defects in mice overexpressing Klf5 in the basal layer of the epidermis J. Cell Sci., September 1, 2006; 119(17): 3593 - 3601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gazel, T. Banno, R. Walsh, and M. Blumenberg Inhibition of JNK Promotes Differentiation of Epidermal Keratinocytes J. Biol. Chem., July 21, 2006; 281(29): 20530 - 20541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wei, M. Kanai, S. Huang, and K. Xie Emerging role of KLF4 in human gastrointestinal cancer Carcinogenesis, January 1, 2006; 27(1): 23 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Ai, Y. Liu, M. Langlois, and T. C. Wang Kruppel-like Factor 4 (KLF4) Represses Histidine Decarboxylase Gene Expression through an Upstream Sp1 Site and Downstream Gastrin Responsive Elements J. Biol. Chem., March 5, 2004; 279(10): 8684 - 8693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakamura, F. Unda, S. de-Vega, A. Vilaxa, S. Fukumoto, K. M. Yamada, and Y. Yamada The Kruppel-like Factor Epiprofin Is Expressed by Epithelium of Developing Teeth, Hair Follicles, and Limb Buds and Promotes Cell Proliferation J. Biol. Chem., January 2, 2004; 279(1): 626 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Roy, S. Khanna, W. A. Wallace, J. Lappalainen, C. Rink, A. J. Cardounel, J. L. Zweier, and C. K. Sen Characterization of Perceived Hyperoxia in Isolated Primary Cardiac Fibroblasts and in the Reoxygenated Heart J. Biol. Chem., November 21, 2003; 278(47): 47129 - 47135. [Abstract] [Full Text] [PDF]
|
|
